Re:Early progress on accelerating drug development with Claude
by kenhwang on Tuesday October 27, 2026 @07:59PM
(#50267621)
That's my understanding as well. Seems like they're improving a $20 part of a billion dollar process, and a part that was already heavily using state of the art AI/simulation at that. The computers already spit out more potential candidates than what can be reasonably tested in vitro.
[ Parent
| on HN ]
Re:Early progress on accelerating drug development with Claude
by timr on Tuesday October 27, 2026 @08:27PM
(#50267825)
> Seems like they're improving a $20 part of a billion dollar process, and a part that was already heavily using state of the art AI/simulation at that. The computers already spit out more potential candidates than what can be reasonably tested in vitro.
This is the fundamental problem with nearly all tech-meets-drugs startups. They almost always focus on the part of the problem where there isn't a bottleneck, because the parts where there is a bottleneck are the parts we don't understand at all.
Re:Early progress on accelerating drug development with Claude
by 10111001 on Tuesday October 27, 2026 @11:18PM
(#50268946)
> This is the fundamental problem with nearly all tech-meets-drugs startups. They almost always focus on the part of the problem where there isn't a bottleneck, because the parts where there is a bottleneck are the parts we don't understand at all.
Are they doing the thing where they develop the technology first, then hunt around for problems for it to solve and hype up potential applications?
Re:Early progress on accelerating drug development with Claude
by timr on Tuesday October 27, 2026 @11:46PM
(#50269140)
Sort of. There’s also a big helping of intellectual arrogance, wherein the tech people think they can apply their same skills to biology, and get the same results.
(I say this as a person who has spent a non-trivial portion of my life as one of those people.)
Re:Early progress on accelerating drug development with Claude
by bamboozled on Tuesday October 27, 2026 @11:38PM
(#50269098)
I don’t see the issue really though, if the $20 part still produces something more likely to get through the billion dollar parts what’s the problem ?
Re:Early progress on accelerating drug development with Claude
by timr on Tuesday October 27, 2026 @11:46PM
(#50269143)
It doesn’t. That’s what I mean when I tell you the bottleneck is somewhere else.
Re-ranking pre-clinical leads is the scientific equivalent of that old saying about opinions.
Re:Early progress on accelerating drug development with Claude
by menaerus on Wednesday October 28, 2026 @04:18AM
(#50270570)
Few years back many SWE people would say, including me, that the bottleneck is not in coding. We were all very wrong.
Re:Early progress on accelerating drug development with Claude
by timr on Wednesday October 28, 2026 @04:50AM
(#50270777)
Not even close to a relevant metaphor. Compared to drug development, coding is trivial. It was always obvious that coding would be the first to fall: there’s a corpus of all the code ever written, the system is fixed in scope and relatively small, the data is text, and it’s all easily validated by machine for correctness.
There is no objective function you can optimize your way to a drug discovery machine, let alone a fundamental understanding of how the underlying system works.
Re:Early progress on accelerating drug development with Claude
by menaerus on Wednesday October 28, 2026 @05:11AM
(#50270891)
I'd take your overly dismissive words as credible (but still wrong) only if you did the career in both disciplines which I assume you didn't. You're wrong, and your view of SWE discipline is a great example of DK effect. Not something one would expect from a PhD in computational biology, yes?